You are currently accessing this Site as a guest. Please login or register by clicking Here
Click here to see who are advancing transfusion alternatives and blood management.
Click here and see who are advancing transfusion alternatives and blood management.

Go Back   NoBlood > General > Press Releases


Welcome to NoBlood.

You are currently accessing this Site as a guest which gives you limited access to most discussions and other features. By registering you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, register today!

If you have any problems with the registration process or your account login, please contact contact us. If you forgot your password, click here to request a new one.

Tags: , , , , ,

Reply
 
LinkBack Thread Tools Rate Thread Display Modes
  #1 (permalink)  
Old 04-24-2005, 10:04 PM
Nika's Avatar
Registered User
 
Join Date: Mar 2005
Posts: 199
Thanks: 0
Thanked 3 Times in 3 Posts
Nika is on a distinguished road
FDA Clears Novare's EndoLink(TM) Articulating Instruments for Marketing; Six Degrees

Source:
PR Newswire

4/6/2005



CUPERTINO, Calif., April 6 /PRNewswire/ -- Novare Surgical Systems Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to market its family of EndoLink surgical instruments, the first single-use hand-held instruments to incorporate six degrees of articulating freedom. Comprised of grasper, dissector, needle drive and scissors, the instruments are used in laparoscopic surgery to enable minimally invasive approaches in gastric bypass, cardiac bypass, pulmonary lobectomy and other general and urologic procedures.



According to Kerry Pope, Novare's president and chief executive officer, the EndoLink system offers the surgeon enhanced anatomical access and device control not available with traditional straight laparoscopic instruments. "Our novel system can be incorporated into instruments as small as 3 millimeters and enable articulation similar to a human wrist. This gives the surgeon greater control and access that can provide important gains in minimally invasive surgery."



EndoLink



Unlike traditional endoscopic instruments that feature four degrees of freedom -- up/down, left/right, rotation, and in/out actuation, the EndoLink instruments also feature the ability to move the wrist left/right and up/down. The additional two degrees of freedom enables a whole new class of minimally invasive procedures, and can significantly reduce the complexity and shorten the learning curve of a number of existing high-volume minimally invasive procedures.



Roger A. de la Torre, M.D., co-director of bariatric services at University of Missouri, Columbia said, "The EndoLink system can eliminate challenges often experienced in complex laparoscopic surgical procedures, such as suturing and knot-tying. The ability to articulate the grasper so that it presents at a 60-to-90 degree angle makes looping the suture a simple task, and can reduce the level of complexity for many general surgical procedures."



"The EndoLink places the surgeon's wrist inside the chest," explains William Mayfield, M.D., thoracic surgeon at Piedmont Hospital in Atlanta. "Instruments that incorporate the EndoLink system are easy to use, intuitive, scalable, and allow the surgeon to perform endoscopically-directed maneuvers that he or she could never perform before with conventional instruments. EndoLink represents a new platform of instrumentation for endoscopic and minimally invasive surgery."



Billy Cohn, M.D., director of minimally invasive surgical technology at Texas Heart Institute, Houston, added, "These fully-articulating instruments have the potential to revolutionize limited access cardiac surgery. The increased range of motion provided by the EndoLink mechanism may indeed prove to be the missing link cardiac surgeons have been searching for in our quest to develop closed-chest cardiac surgical procedures. By combining this technology with current videoscopic visualization, new approaches for treating valve disease, cardiac rhythm disturbances, and other heart disease will naturally evolve. It is a very exciting development for our field."



About Novare Surgical Systems



Based in Cupertino, Calif., Novare Surgical Systems Inc. was founded in 1999 to develop, manufacture and market proprietary devices for minimally invasive and traditional surgical procedures. The company has commercialized the Intrack(R) family of atraumatic occlusion devices, which includes the Engage(R), Cygnet(R), Novaclip(R) and Greyhound(R) product lines. Enclose(R), an assist device for multiple proximal anastomoses in coronary artery bypass graft (CABG) surgery, was introduced in 2002. For more information, visit the company's web site at http://www.novaresurgical.com/ .



CONTACT: Kerry Pope, President & CEO, of Novare Surgical Systems Inc., +1-408-350-9912, or kpope@novaresurgical.com; or Charles Versaggi, Ph.D., of Versaggi Biocommunications, +1-415-397-3087, or cv@versaggibio.com, for Novare Surgical Systems Inc.



Web site: http://www.novaresurgical.com/

Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

  NoBlood > General > Press Releases



Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools
Display Modes Rate This Thread
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is Off
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
FDA Clears Valleylab's Cool-Tip RF Ablation System for Use in Ablating Non-Resectable Sharon Grant News and Hot Topics such as Hepatitis C, SARS and AIDS 0 05-13-2006 08:35 PM
Program Marketing Deborah Tolich Shop Talk 0 03-17-2004 09:18 AM
Biopure Receives FDA Response to Hemopure(R) Marketing Application Jan B. Wade Press Releases 0 08-01-2003 10:10 AM
U.S. FDA Finalizes Response Date for Biopure's Marketing Application of Hemopure Jan B. Wade Press Releases 0 05-30-2003 02:55 PM


All times are GMT -7. The time now is 01:08 AM.






Featured
Hospital Sponsors
Hospitals Directory

Click here to help us make a difference today. Yes, for the price of a cup of coffee, you can help NoBlood continue its mission to advance knowledge and awareness of transfusion alternatives, blood conservation, blood management, bloodless medicine and bloodless surgery.
Please help us continue to make a difference today.

Highlights
Looking for help?
Can you help?

Key Wiki Articles
Register - FAQ - Members List - Calendar - Files - Videos - Mark Forums Read - NoBlood.org RSS Feeds

Powered by vBulletin® Version 3.6.10
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
SEO by vBSEO 3.1.0
Copyright © 1996 - 2008, Bloodless Healthcare International, Inc.